HEADER TRANSLATION 27-JUL-23 8TLV
TITLE CRYSTAL STRUCTURE OF MBP AND AF9 AHD FUSION PROTEIN 4AQK IN COMPLEX
TITLE 2 WITH PEPTIDOMIMETIC INHIBITOR 28
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: MBP AND AF9 AHD FUSION PROTEIN 4AQK;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: MMBP,MALTODEXTRIN-BINDING PROTEIN,MALTOSE-BINDING PROTEIN,
COMPND 5 MBP;
COMPND 6 ENGINEERED: YES;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: PEPTIDOMIMETIC INHIBITOR 28;
COMPND 9 CHAIN: B;
COMPND 10 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI K-12, HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 83333, 9606;
SOURCE 5 STRAIN: K12;
SOURCE 6 GENE: MALE, B4034, JW3994;
SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 9 MOL_ID: 2;
SOURCE 10 SYNTHETIC: YES;
SOURCE 11 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT;
SOURCE 12 ORGANISM_TAXID: 32630
KEYWDS MLL FUSION SUPER ELONGATION COMPLEX (SEC) ACUTE LYMPHOBLASTIC
KEYWDS 2 LEUKEMIA ACUTE MYELOID LEUKEMIA, TRANSLATION
EXPDTA X-RAY DIFFRACTION
AUTHOR Y.YANG,Z.NIKOLOVSKA-COLESKA
REVDAT 2 11-SEP-24 8TLV 1 REMARK DBREF SEQADV HELIX
REVDAT 2 2 1 SHEET SSBOND ATOM
REVDAT 1 29-MAY-24 8TLV 0
JRNL AUTH Y.YANG,E.AHMAD,V.PREMKUMAR,A.LIU,S.M.ASHIKUR RAHMAN,
JRNL AUTH 2 Z.NIKOLOVSKA-COLESKA
JRNL TITL STRUCTURAL STUDIES OF INTRINSICALLY DISORDERED MLL-FUSION
JRNL TITL 2 PROTEIN AF9 IN COMPLEX WITH PEPTIDOMIMETIC INHIBITORS.
JRNL REF PROTEIN SCI. V. 33 E5019 2024
JRNL REFN ESSN 1469-896X
JRNL PMID 38747396
JRNL DOI 10.1002/PRO.5019
REMARK 2
REMARK 2 RESOLUTION. 2.66 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.10.4 (17-FEB-2023)
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.66
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.39
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0
REMARK 3 NUMBER OF REFLECTIONS : 14920
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.207
REMARK 3 R VALUE (WORKING SET) : 0.202
REMARK 3 FREE R VALUE : 0.246
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.160
REMARK 3 FREE R VALUE TEST SET COUNT : 1516
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 51
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.66
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.68
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.66
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 299
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2772
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 273
REMARK 3 BIN R VALUE (WORKING SET) : 0.2814
REMARK 3 BIN FREE R VALUE : 0.2338
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.70
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3334
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 43
REMARK 3 SOLVENT ATOMS : 67
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.77
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -17.71050
REMARK 3 B22 (A**2) : 16.92460
REMARK 3 B33 (A**2) : 0.78590
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.330
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 1.013
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.311
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.938
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.315
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.920
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.899
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 3461 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 4727 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1158 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL
REMARK 3 GENERAL PLANES : 587 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 3461 ; 10.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 472 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 2704 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.007
REMARK 3 BOND ANGLES (DEGREES) : 0.89
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.57
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.88
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 8TLV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JUL-23.
REMARK 100 THE DEPOSITION ID IS D_1000276180.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 14-JUL-22
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 21-ID-D
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.12705
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14943
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650
REMARK 200 RESOLUTION RANGE LOW (A) : 200.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3
REMARK 200 DATA REDUNDANCY : 8.600
REMARK 200 R MERGE (I) : 0.09000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.9000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70
REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6
REMARK 200 DATA REDUNDANCY IN SHELL : 6.20
REMARK 200 R MERGE FOR SHELL (I) : 0.57600
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 52.70
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 20-30% PEG3350, 0.1 M HEPES PH 7.5,
REMARK 280 AND 0.2 M AMMONIUM ACETATE, VAPOR DIFFUSION, SITTING DROP,
REMARK 280 TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -X,Y,-Z+1/2
REMARK 290 4555 X,-Y,-Z
REMARK 290 5555 X+1/2,Y+1/2,Z
REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2
REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2
REMARK 290 8555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.83000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.83000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 50.95300
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 78.44700
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 50.95300
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 78.44700
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 31.83000
REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 50.95300
REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 78.44700
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 31.83000
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 50.95300
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 78.44700
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 2470 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 18320 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 SER A -2
REMARK 465 GLY A -1
REMARK 465 GLY A 0
REMARK 465 SER A 1
REMARK 465 GLU A 563
REMARK 465 THR A 564
REMARK 465 SER A 565
REMARK 465 GLY A 566
REMARK 465 THR A 567
REMARK 465 SER A 568
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 2 CG CD CE NZ
REMARK 470 GLU A 4 CG CD OE1 OE2
REMARK 470 LYS A 7 CD CE NZ
REMARK 470 GLU A 23 CG CD OE1 OE2
REMARK 470 LYS A 26 CE NZ
REMARK 470 LYS A 27 CD CE NZ
REMARK 470 LYS A 30 CD CE NZ
REMARK 470 LYS A 35 CG CD CE NZ
REMARK 470 GLN A 50 CD OE1 NE2
REMARK 470 LYS A 84 CG CD CE NZ
REMARK 470 LYS A 89 CE NZ
REMARK 470 LYS A 138 CD CE NZ
REMARK 470 GLU A 139 OE1 OE2
REMARK 470 LYS A 171 CG CD CE NZ
REMARK 470 GLU A 173 CG CD OE1 OE2
REMARK 470 ASN A 174 CG OD1 ND2
REMARK 470 LYS A 176 CE NZ
REMARK 470 LYS A 180 CD CE NZ
REMARK 470 LYS A 201 CE NZ
REMARK 470 LYS A 203 CG CD CE NZ
REMARK 470 ASP A 208 OD1 OD2
REMARK 470 LYS A 220 CE NZ
REMARK 470 GLU A 275 CG CD OE1 OE2
REMARK 470 LYS A 296 CG CD CE NZ
REMARK 470 LYS A 298 CE NZ
REMARK 470 GLU A 310 CG CD OE1 OE2
REMARK 470 GLU A 311 CG CD OE1 OE2
REMARK 470 LYS A 314 CG CD CE NZ
REMARK 470 LYS A 363 CG CD CE NZ
REMARK 470 ARG A 520 CG CD NE CZ NH1 NH2
REMARK 470 HIS A 521 CG ND1 CD2 CE1 NE2
REMARK 470 GLN A 525 CG CD OE1 NE2
REMARK 470 GLU A 532 CD OE1 OE2
REMARK 470 LYS A 557 CG CD CE NZ
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LEU A 123 87.10 -150.23
REMARK 500 TYR A 172 47.14 -96.78
REMARK 500 GLU A 519 99.46 -64.35
REMARK 500
REMARK 500 REMARK: NULL
DBREF 8TLV A 2 367 UNP P0AEX9 MALE_ECOLI 27 392
DBREF 8TLV A 500 568 UNP B7Z4N5 B7Z4N5_HUMAN 539 607
DBREF 8TLV B 1 6 PDB 8TLV 8TLV 1 6
SEQADV 8TLV SER A -2 UNP P0AEX9 EXPRESSION TAG
SEQADV 8TLV GLY A -1 UNP P0AEX9 EXPRESSION TAG
SEQADV 8TLV GLY A 0 UNP P0AEX9 EXPRESSION TAG
SEQADV 8TLV SER A 1 UNP P0AEX9 EXPRESSION TAG
SEQADV 8TLV CYS A 336 UNP P0AEX9 GLN 361 ENGINEERED MUTATION
SEQADV 8TLV ALA A 368 UNP P0AEX9 LINKER
SEQADV 8TLV ALA A 369 UNP P0AEX9 LINKER
SEQADV 8TLV ALA A 370 UNP P0AEX9 LINKER
SEQADV 8TLV ALA A 371 UNP P0AEX9 LINKER
SEQADV 8TLV CYS A 501 UNP B7Z4N5 LYS 540 ENGINEERED MUTATION
SEQRES 1 A 443 SER GLY GLY SER LYS ILE GLU GLU GLY LYS LEU VAL ILE
SEQRES 2 A 443 TRP ILE ASN GLY ASP LYS GLY TYR ASN GLY LEU ALA GLU
SEQRES 3 A 443 VAL GLY LYS LYS PHE GLU LYS ASP THR GLY ILE LYS VAL
SEQRES 4 A 443 THR VAL GLU HIS PRO ASP LYS LEU GLU GLU LYS PHE PRO
SEQRES 5 A 443 GLN VAL ALA ALA THR GLY ASP GLY PRO ASP ILE ILE PHE
SEQRES 6 A 443 TRP ALA HIS ASP ARG PHE GLY GLY TYR ALA GLN SER GLY
SEQRES 7 A 443 LEU LEU ALA GLU ILE THR PRO ASP LYS ALA PHE GLN ASP
SEQRES 8 A 443 LYS LEU TYR PRO PHE THR TRP ASP ALA VAL ARG TYR ASN
SEQRES 9 A 443 GLY LYS LEU ILE ALA TYR PRO ILE ALA VAL GLU ALA LEU
SEQRES 10 A 443 SER LEU ILE TYR ASN LYS ASP LEU LEU PRO ASN PRO PRO
SEQRES 11 A 443 LYS THR TRP GLU GLU ILE PRO ALA LEU ASP LYS GLU LEU
SEQRES 12 A 443 LYS ALA LYS GLY LYS SER ALA LEU MET PHE ASN LEU GLN
SEQRES 13 A 443 GLU PRO TYR PHE THR TRP PRO LEU ILE ALA ALA ASP GLY
SEQRES 14 A 443 GLY TYR ALA PHE LYS TYR GLU ASN GLY LYS TYR ASP ILE
SEQRES 15 A 443 LYS ASP VAL GLY VAL ASP ASN ALA GLY ALA LYS ALA GLY
SEQRES 16 A 443 LEU THR PHE LEU VAL ASP LEU ILE LYS ASN LYS HIS MET
SEQRES 17 A 443 ASN ALA ASP THR ASP TYR SER ILE ALA GLU ALA ALA PHE
SEQRES 18 A 443 ASN LYS GLY GLU THR ALA MET THR ILE ASN GLY PRO TRP
SEQRES 19 A 443 ALA TRP SER ASN ILE ASP THR SER LYS VAL ASN TYR GLY
SEQRES 20 A 443 VAL THR VAL LEU PRO THR PHE LYS GLY GLN PRO SER LYS
SEQRES 21 A 443 PRO PHE VAL GLY VAL LEU SER ALA GLY ILE ASN ALA ALA
SEQRES 22 A 443 SER PRO ASN LYS GLU LEU ALA LYS GLU PHE LEU GLU ASN
SEQRES 23 A 443 TYR LEU LEU THR ASP GLU GLY LEU GLU ALA VAL ASN LYS
SEQRES 24 A 443 ASP LYS PRO LEU GLY ALA VAL ALA LEU LYS SER TYR GLU
SEQRES 25 A 443 GLU GLU LEU ALA LYS ASP PRO ARG ILE ALA ALA THR MET
SEQRES 26 A 443 GLU ASN ALA GLN LYS GLY GLU ILE MET PRO ASN ILE PRO
SEQRES 27 A 443 CYS MET SER ALA PHE TRP TYR ALA VAL ARG THR ALA VAL
SEQRES 28 A 443 ILE ASN ALA ALA SER GLY ARG GLN THR VAL ASP GLU ALA
SEQRES 29 A 443 LEU LYS ASP ALA GLN THR ALA ALA ALA ALA ASP CYS ALA
SEQRES 30 A 443 TYR LEU ASP GLU LEU VAL GLU LEU HIS ARG ARG LEU MET
SEQRES 31 A 443 THR LEU ARG GLU ARG HIS ILE LEU GLN GLN ILE VAL ASN
SEQRES 32 A 443 LEU ILE GLU GLU THR GLY HIS PHE HIS ILE THR ASN THR
SEQRES 33 A 443 THR PHE ASP PHE ASP LEU CYS SER LEU ASP LYS THR THR
SEQRES 34 A 443 VAL ARG LYS LEU GLN SER TYR LEU GLU THR SER GLY THR
SEQRES 35 A 443 SER
SEQRES 1 B 6 HBX PRO VAL DPP XYC I6O
HET HBX B 1 8
HET DPP B 4 6
HET XYC B 5 10
HET I6O B 6 23
HET GLC C 1 12
HET GLC C 2 11
HET GSH A 601 20
HETNAM HBX BENZALDEHYDE
HETNAM DPP DIAMINOPROPANOIC ACID
HETNAM XYC (2~{S})-2-AZANYL-3-CYCLOPENTYL-PROPANOIC ACID
HETNAM I6O 1-(CYCLOHEXYLMETHYL)-4-PHENYL-2-[(2S)-PYRROLIDIN-2-YL]-
HETNAM 2 I6O 1H-IMIDAZOLE
HETNAM GLC ALPHA-D-GLUCOPYRANOSE
HETNAM GSH GLUTATHIONE
HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE
FORMUL 2 HBX C7 H6 O
FORMUL 2 DPP C3 H8 N2 O2
FORMUL 2 XYC C8 H15 N O2
FORMUL 2 I6O C20 H27 N3
FORMUL 3 GLC 2(C6 H12 O6)
FORMUL 4 GSH C10 H17 N3 O6 S
FORMUL 5 HOH *67(H2 O)
HELIX 1 AA1 GLY A 17 GLY A 33 1 17
HELIX 2 AA2 LYS A 43 ALA A 53 1 11
HELIX 3 AA3 ARG A 67 SER A 74 1 8
HELIX 4 AA4 ASP A 83 ASP A 88 1 6
HELIX 5 AA5 TYR A 91 VAL A 98 1 8
HELIX 6 AA6 THR A 129 GLU A 131 5 3
HELIX 7 AA7 GLU A 132 LYS A 143 1 12
HELIX 8 AA8 GLU A 154 ASP A 165 1 12
HELIX 9 AA9 ASN A 186 ASN A 202 1 17
HELIX 10 AB1 ASP A 210 LYS A 220 1 11
HELIX 11 AB2 GLY A 229 TRP A 231 5 3
HELIX 12 AB3 ALA A 232 LYS A 240 1 9
HELIX 13 AB4 ASN A 273 TYR A 284 1 12
HELIX 14 AB5 THR A 287 LYS A 298 1 12
HELIX 15 AB6 LEU A 305 ALA A 313 1 9
HELIX 16 AB7 ASP A 315 GLY A 328 1 14
HELIX 17 AB8 CYS A 336 SER A 353 1 18
HELIX 18 AB9 THR A 357 LEU A 517 1 33
HELIX 19 AC1 GLU A 519 GLY A 534 1 16
HELIX 20 AC2 ASP A 551 TYR A 561 1 11
SHEET 1 AA1 6 LYS A 35 GLU A 39 0
SHEET 2 AA1 6 LYS A 7 TRP A 11 1 N ILE A 10 O GLU A 39
SHEET 3 AA1 6 ILE A 60 ALA A 64 1 O PHE A 62 N TRP A 11
SHEET 4 AA1 6 PHE A 259 ILE A 267 -1 O SER A 264 N TRP A 63
SHEET 5 AA1 6 TYR A 107 GLU A 112 -1 N ILE A 109 O LEU A 263
SHEET 6 AA1 6 ALA A 302 VAL A 303 -1 O ALA A 302 N VAL A 111
SHEET 1 AA2 5 LYS A 35 GLU A 39 0
SHEET 2 AA2 5 LYS A 7 TRP A 11 1 N ILE A 10 O GLU A 39
SHEET 3 AA2 5 ILE A 60 ALA A 64 1 O PHE A 62 N TRP A 11
SHEET 4 AA2 5 PHE A 259 ILE A 267 -1 O SER A 264 N TRP A 63
SHEET 5 AA2 5 GLU A 329 ILE A 330 1 O GLU A 329 N VAL A 260
SHEET 1 AA3 2 ARG A 99 TYR A 100 0
SHEET 2 AA3 2 LYS A 103 LEU A 104 -1 O LYS A 103 N TYR A 100
SHEET 1 AA4 4 SER A 146 LEU A 148 0
SHEET 2 AA4 4 THR A 223 ASN A 228 1 O ALA A 224 N SER A 146
SHEET 3 AA4 4 SER A 115 ASN A 119 -1 N ILE A 117 O THR A 226
SHEET 4 AA4 4 TYR A 243 THR A 246 -1 O THR A 246 N LEU A 116
SHEET 1 AA5 2 TYR A 168 LYS A 171 0
SHEET 2 AA5 2 ASP A 178 GLY A 183 -1 O ASP A 178 N LYS A 171
SHEET 1 AA6 2 THR A 250 PHE A 251 0
SHEET 2 AA6 2 GLN A 254 PRO A 255 -1 O GLN A 254 N PHE A 251
SHEET 1 AA7 3 HIS A 537 ILE A 538 0
SHEET 2 AA7 3 PHE A 543 PHE A 545 -1 O ASP A 544 N HIS A 537
SHEET 3 AA7 3 VAL B 3 XYC B 5 -1 O VAL B 3 N PHE A 545
SSBOND 1 CYS A 336 CYS A 501 1555 1555 2.04
LINK C1' HBX B 1 N PRO B 2 1555 1555 1.34
LINK C VAL B 3 N DPP B 4 1555 1555 1.34
LINK C DPP B 4 N XYC B 5 1555 1555 1.34
LINK C XYC B 5 N I6O B 6 1555 1555 1.35
LINK O4 GLC C 1 C1 GLC C 2 1555 1555 1.43
CRYST1 101.906 156.894 63.660 90.00 90.00 90.00 C 2 2 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009813 0.000000 0.000000 0.00000
SCALE2 0.000000 0.006374 0.000000 0.00000
SCALE3 0.000000 0.000000 0.015708 0.00000